Sponsor

Fundacion Cris De Investigacion Para Vencer El Cancer

Spain Avenida Manoteras 22, Poligono De Manoteras, 28050 Madrid, Spain

About the sponsor

Research activity in muscle-invasive bladder cancer centers on post-treatment disease control, with interest in immunotherapy strategies and outcomes after trimodality therapy.

Durvalumab in bladder cancer
Disease-free survival
Adjuvant treatment
Surveillance

The sponsor’s work in this area reflects a focus on integrating immune-based treatment approaches into the management of locally advanced bladder cancer.

About Specializations

Fundacion Cris De Investigacion Para Vencer El Cancer runs clinical trials in conditions such as Bladder transitional cell carcinoma stage III, Bladder transitional cell carcinoma stage II, Chronic myeloid leukaemia, among others.

All trials